Status: Not yet recruiting
Efficacy and Safety of CRT, Durvalumab and Surgery for SST
The safety and efficacy of multimodality treatment of pre- and post-operative durvalumab therapy after pre-operative chemoradiotherapy for resectable superior sulcus tumor (SST) and durvalumab maintenance therapy after chemoradiotherapy for unresectable SST
Participants needed: 84
Trial details
Phase: Phase 3Age: 20-75Biological sex: AllType: InterventionalSponsor: National Cancer Center Hospital EastUpdated: Jul 10, 2020
Eligibility criteria
A definite diagnosis of non-small cell lung cancer has been obtained by biopsy f... [+18]
Having active double cancer (simultaneous double cancer/multiple cancer and meta... [+18]